158 related articles for article (PubMed ID: 6152198)
1. Neurotransmitters and neurodegenerative disorders.
Kanazawa I
Clin Ther; 1984; 7 Spec No():48-58. PubMed ID: 6152198
[TBL] [Abstract][Full Text] [Related]
2. Neurochemical anatomy of movement disorders.
Young AB; Penney JB
Neurol Clin; 1984 Aug; 2(3):417-33. PubMed ID: 6152481
[TBL] [Abstract][Full Text] [Related]
3. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
[TBL] [Abstract][Full Text] [Related]
4. [GABA and diseases of the extrapyramidal system].
Carrieri P
Acta Neurol (Napoli); 1977; 32(5):697-704. PubMed ID: 22223
[No Abstract] [Full Text] [Related]
5. Role of excitotoxins in heredito-degenerative neurologic diseases.
Young AB
Res Publ Assoc Res Nerv Ment Dis; 1993; 71():175-89. PubMed ID: 8093331
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress in Parkinson's disease and other neurodegenerative disorders.
Jenner P
Pathol Biol (Paris); 1996 Jan; 44(1):57-64. PubMed ID: 8734302
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in neural transplantation. Relevance to neurodegenerative disorders.
Borlongan CV; Cahill DW; Freeman TB; Sanberg PR
J Fla Med Assoc; 1994 Oct; 81(10):689-94. PubMed ID: 7798875
[TBL] [Abstract][Full Text] [Related]
8. Recent developments in Parkinson's disease and Huntington's chorea.
Barbeau A
Int J Neurol; 1976; 11(1):17-27. PubMed ID: 138661
[No Abstract] [Full Text] [Related]
9. Dysfunction of the basal ganglia, but not the cerebellum, impairs kinaesthesia.
Maschke M; Gomez CM; Tuite PJ; Konczak J
Brain; 2003 Oct; 126(Pt 10):2312-22. PubMed ID: 12821507
[TBL] [Abstract][Full Text] [Related]
10. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
11. Neurochemistry of dementia.
Whitehouse PJ; Unnerstall JR
Eur Neurol; 1988; 28 Suppl 1():36-41. PubMed ID: 2967756
[TBL] [Abstract][Full Text] [Related]
12. [Changes in brain level of neurotransmitters].
Kanazawa I
Nihon Naika Gakkai Zasshi; 1991 Jul; 80(7):1148-52. PubMed ID: 1680945
[No Abstract] [Full Text] [Related]
13. Monoamine transmitters and their metabolites in the basal ganglia of Huntington's disease and control postmortem brain.
Walsh FX; Bird ED; Stevens TJ
Adv Neurol; 1982; 35():165-9. PubMed ID: 6183949
[No Abstract] [Full Text] [Related]
14. Biomarkers in Huntington's and Parkinson's Disease.
O'Keeffe GC; Michell AW; Barker RA
Ann N Y Acad Sci; 2009 Oct; 1180():97-110. PubMed ID: 19906264
[TBL] [Abstract][Full Text] [Related]
15. [Amino acid metabolism in neurodegenerative diseases].
Nakamura S
Nihon Rinsho; 1992 Jul; 50(7):1637-42. PubMed ID: 1357203
[TBL] [Abstract][Full Text] [Related]
16. Error processing in normal aging and in basal ganglia disorders.
Beste C; Willemssen R; Saft C; Falkenstein M
Neuroscience; 2009 Mar; 159(1):143-9. PubMed ID: 19166908
[TBL] [Abstract][Full Text] [Related]
17. BAC to degeneration bacterial artificial chromosome (BAC)-mediated transgenesis for modeling basal ganglia neurodegenerative disorders.
Lu XH
Int Rev Neurobiol; 2009; 89():37-56. PubMed ID: 19900614
[TBL] [Abstract][Full Text] [Related]
18. [Neurotransmitters in Huntington chorea (review)].
Barkhatova VP; Larskiĭ EG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):444-50. PubMed ID: 2581405
[No Abstract] [Full Text] [Related]
19. Putative peptide neurotransmitters in human neuropathology: a review of topography and clinical implications.
Constantinidis J; Bouras C; Richard J
Clin Neuropathol; 1983; 2(2):47-54. PubMed ID: 6189657
[TBL] [Abstract][Full Text] [Related]
20. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.
Outeiro TF; Giorgini F
Biotechnol J; 2006 Mar; 1(3):258-69. PubMed ID: 16897706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
